Acral Lentiginous Melanoma

Common Name(s)

Acral Lentiginous Melanoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Acral Lentiginous Melanoma" for support, advocacy or research.

Logo
Melanoma International Foundation

The mission of the Melanoma International Foundation is to develop personalized strategies with patients so they may live longer, better lives.

Last Updated: 29 Jun 2015

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Acral Lentiginous Melanoma" for support, advocacy or research.

Logo
Melanoma International Foundation

The mission of the Melanoma International Foundation is to develop personalized strategies with patients so they may live longer, better lives.

http://www.melanomainternational.org

Last Updated: 29 Jun 2015

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Acral Lentiginous Melanoma" returned 13 free, full-text research articles on human participants. First 3 results:

Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
 

Author(s): Yi-Shuan Sheen, Yi-Hua Liao, Ming-Hsien Lin, Hsien-Ching Chiu, Shiou-Hwa Jee, Jau-Yu Liau, Yih-Leong Chang, Chia-Yu Chu

Journal:

 

Insulin-like growth factor-II mRNA-binding protein 3 (IMP-3) is an RNA-binding protein expressed in multiple cancers, including melanomas. However, the expression of IMP-3 has not been investigated in acral lentiginous melanoma (ALM). This study sought to elucidate its prognostic ...

Last Updated: 22 Jan 2016

Go To URL
IMAGES IN CLINICAL MEDICINE. Acral Lentiginous Melanoma.
 

Author(s): Mildred P Warren, Valerie M Harvey

Journal: N. Engl. J. Med.. 2015 Nov;373(19):1864.

 

Last Updated: 5 Nov 2015

Go To URL
Focal invasiveness in complete histological analyses of a large acral lentiginous melanoma.
 

Author(s): José Cândido Caldeira Xavier-Júnior, Tania Munhoz, Vinicius Souza, Eloísa Bueno Pires de Campos, Hamilton Ometto Stolf, Mariângela Esther Alencar Marques

Journal:

 

Acral lentiginous melanoma is a melanoma with poor prognosis which is frequently diagnosed at an advanced stage. Since the thickness of tumour is one of the main prognostic factors, this case can exemplify how important complete histological analyses looking for focal invasiveness can be.

Last Updated: 19 Jun 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Acral Lentiginous Melanoma" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
 

Status: Not yet recruiting

Condition Summary: Acral Lentiginous Melanoma

 

Last Updated: 17 Aug 2016

Go to URL
A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread
 

Status: Recruiting

Condition Summary: Mucosal Lentiginous Melanoma; Acral Lentiginous Malignant Melanoma

 

Last Updated: 18 May 2012

Go to URL